Atazanavir Sulfate
- Product NDC
- 60687-399
- 11-digit product format
- 606870399
- Labeler code
- 60687
- Product ID
- 60687-399_86549ef5-0809-3c5a-e053-2991aa0a16d3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atazanavir
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- ANDA204806
- Marketing category
- ANDA
- Marketing start
- 2018-09-12
- Marketing end
- 2020-05-31
- Substance
- ATAZANAVIR SULFATE
- Active strength
- 300 mg/1
- Pharmacologic classes
- HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record